RecruitingNot ApplicableNCT05768217

Community Resiliency Collective Efficacy Intervention

Community Resiliency Collective Efficacy Intervention (CRCEI) for Prevention of Community Violence - A Cluster Randomized Controlled Trial


Sponsor

University of Pittsburgh

Enrollment

4,600 participants

Start Date

Jun 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.


Eligibility

Min Age: 13 Years

Inclusion Criteria3

  • youth age 13 years old and up (all genders)
  • adults 18 years and older (all genders)
  • reside in neighborhoods selected to participate in the study

Exclusion Criteria2

  • individuals younger than 13 years old
  • individuals residing outside of participating neighborhoods

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCommunity Resiliency Collective Efficacy Intervention (CRCEI)

The Community Resiliency Collective Efficacy Intervention (CRCEI) will involve community members in dialogue on thriving, community leadership, and organizing for social change. Participants in the intervention condition will be asked to participate in 2 sessions of discussions about community thriving and a 7-week training program on the following topics: Building on the Strengths of Your Community, Collective Efficacy and its Effects on Violence Prevention \& Community Mental Health, Non-threatening Peaceful Intervention Principles and Strategies: Part One, Non-threatening Peaceful Intervention Principles and Strategies: Part Two, Safety and Roles of Police and Community in Intervening, Active/Effective listening and non-violent communication skills, and Community Resources and Indirect Intervention.

BEHAVIORALHealth Education Sessions

Comparison neighborhoods will receive health education sessions across a variety of community-identified health topics as a control intervention. (9 sessions)


Locations(1)

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05768217


Related Trials